Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TASK: TMP-SMX for UTI Prevention in Kidney Transplant Recipients
NCT07106125Phase 4Not yet recruiting
- Sponsor
- University of California, San Francisco
- Start
- Oct 2028
- Primary completion
- Dec 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in urinary tract infection (UTI) comparing TMP-SMX with Placebo (2 arms). Primary endpoints: Agreement Between Participant Self-Report and Medical Records on Clinical Events at 6 months, Number of Participants Who Enroll After Screening and 2 more. Planned start Oct 2028; status: not yet recruiting.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT07106125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07106125.